17. Mar 2023
4SC AG: Developing innovative drugs for cancer patients
Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biopharmaceutical company with a strong focus on product development in oncology.
We develop novel small molecule drugs for the treatment of cancer in indications with a high unmet medical need and significant economic potential.
We wish to offer affected patients treatment options that are more effective and better tolerated to provide a better quality of life.
Our product pipeline comprises promising drug programs at various stages of clinical development. We are focusing on fields of research that contribute to the development and persistence of cancer.